2005
DOI: 10.1016/j.cmet.2005.07.001
|View full text |Cite
|
Sign up to set email alerts
|

Increased dosage of mammalian Sir2 in pancreatic β cells enhances glucose-stimulated insulin secretion in mice

Abstract: Sir2 NAD-dependent deacetylases connect transcription, metabolism, and aging. Increasing the dosage or activity of Sir2 extends life span in yeast, worms, and flies and promotes fat mobilization and glucose production in mammalian cells. Here we show that increased dosage of Sirt1, the mammalian Sir2 ortholog, in pancreatic beta cells improves glucose tolerance and enhances insulin secretion in response to glucose in beta cell-specific Sirt1-overexpressing (BESTO) transgenic mice. This phenotype is maintained … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

14
551
2
6

Year Published

2006
2006
2015
2015

Publication Types

Select...
5
5

Relationship

0
10

Authors

Journals

citations
Cited by 584 publications
(573 citation statements)
references
References 47 publications
14
551
2
6
Order By: Relevance
“…Sirtuins have seven homologs in humans and mice (SIRT1-7) [78,79]. SIRT1 is considered to be a nuclear enzyme [80], although it may also appear in the cytosol [81]. SIRT1 is an NAD + -dependent protein deacetylase [82] that enables SIRT1 to sense the energetic status of cells (e.g.…”
Section: Nuclear Receptor Signalingmentioning
confidence: 99%
“…Sirtuins have seven homologs in humans and mice (SIRT1-7) [78,79]. SIRT1 is considered to be a nuclear enzyme [80], although it may also appear in the cytosol [81]. SIRT1 is an NAD + -dependent protein deacetylase [82] that enables SIRT1 to sense the energetic status of cells (e.g.…”
Section: Nuclear Receptor Signalingmentioning
confidence: 99%
“…Published evidence suggests that SirT1 prevents ageassociated diseases such as metabolic disorders (Picard et al, 2004;Kitamura et al, 2005;Moynihan et al, 2005;Bordone et al, 2006;Gerhart-Hines et al, 2007;Rodgers and Puigserver, 2007), neurodegenerative diseases (Araki et al, 2004;Parker et al, 2005;Chen et al, 2005a;Qin et al, 2006;Kim et al, 2007) and atherosclerosis . Accumulating evidence also point to SirT1 as having a function in cancer; however, inferences from the literature are that SirT1 has both oncogenic and tumor-suppressor activities.…”
Section: Introductionmentioning
confidence: 99%
“…SIRT1 and glucose/lipid metabolism SIRT1 has been connected with glucose and lipid metabolism (Moynihan et al, 2005;Picard et al, 2004;Rodgers and Puigserver, 2007;Rodgers et al, 2005). Glucose uptake in peripheral tissues is promoted by insulin, thus insulin-secreting pancreatic beta cells are crucial in the regulation of glucose metabolism.…”
Section: Sirt1mentioning
confidence: 99%